General Announcement::Restructuring of Consumer Business and Update on Proposed Joint Venture With Orion Specialty Labs

Issuer & Securities

Issuer/ Manager
IX BIOPHARMA LTD.
Securities
IX BIOPHARMA LTD. - SG1BD9000009 - 42C
IX BIOPHARMA LTD. W260718 - SGXN57296778 - HQXW
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
11-May-2026 07:24:09
Status
New
Announcement Sub Title
Restructuring of Consumer Business and Update on Proposed Joint Venture With Orion Specialty Labs
Announcement Reference
SG260511OTHRE3CY
Submitted By (Co./ Ind. Name)
Gwendolin Lee Soo Fern
Designation
Company Secretary
Description (Please provide a detailed description of the event in the box below)

Please see attached.

Attachments

Announcement - Proposed Restructuring final 11 May 2026.pdf
Total size =42K